Eric Luthi

Eric Luthi's work experience includes a variety of roles in the pharmaceutical industry. Eric is currently serving as the Chief Commercial Officer at Evergreen Theragnostics since February 2023. Prior to this, they worked at Idorsia Pharmaceuticals Ltd, where they served as the General Manager for Canada, responsible for establishing the legal entity, hiring the leadership team, and launching the company's first product. Eric also held the position of Vice President for Global Marketing, where they built the marketing team and oversaw the launch of daridorexant, a medication for insomnia.

Before their time at Idorsia Pharmaceuticals, Eric worked at Merck in various roles including Head of Digital and Commercial Operations, Primary Care and Vaccines Business Leader, Executive Director of Global Brand Leader for Insomnia, Sr. Director of New Products in the Cardiovascular division, and Director of Corporate Strategy.

Eric also worked at Tengion, Inc. as the Director of Business Development & Marketing, and at Merck earlier in their career, where they held roles such as Sr. Product Manager for Hypertension, Market Research Analyst, and Sales Representative.

Eric Luthi attended Muhlenberg College from 1990 to 1994, where they pursued a Bachelor of Science degree in Biology and Psychology.